Teva Pharmaceutical News (NASDAQ:TEVA)
| Latest Teva Pharmaceutical News Headlines | | Date | Time | Source | | | 07/18/2008 | 7:00AM | PRNUS | Teva to Acquire Barr
Significantly Strengthens Teva's Market Leadership Position in the U.S. and in Key Global Markets
JERUSALEM and MONTVALE, N.J., July 18 /PRNewswire-FirstCall/ -- Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) and Barr Pharmaceuticals, Inc. (NYSE:BRL) announced today that they have signed a definitive agreement under... More...>> |
| 06/18/2008 | 9:00AM | PRNUS | BeaconEquity.com Issues TraderNotes on MCII, NOEC, MENT, HYHY, IVAN, RUNU, TEVA, CTXS
DALLAS, June 18 /PRNewswire/ -- BeaconEquity.com announces the availability of TraderNotes on stocks that are making news today.
Investors can view all of the daily trading notes for free by visiting: http://www.beaconequity.com/m
Today's TraderNotes include: Mariner's Choice (Pink Sheets: MCII), New Oriental Energy... More...>> |
| 06/10/2008 | 11:20AM | PRNUS | Seven Summits Research Releases Comments on BIDU, TXN, FCX, BRCM, and TEVA
CHICAGO, June 10 /PRNewswire/ -- Seven Summits Research releases NewsBites on key stocks.
Seven Summits Strategic Investments NewsBites are available to all investors at:
http://www.go7now.com/nb/0610Y (Note: You may have to copy this link into your browser then press the [ENTER] key.)
Today's Seven Summits Strategic... More...>> |
| 05/05/2008 | 9:31AM | PRNUS | Seven Summits Research Releases Comments on NYX, TEVA, DIS, ABX and EGLE
CHICAGO, May 5 /PRNewswire/ -- Seven Summits Strategic Investments releases its Stocks To Watch Guide.
The Seven Summits Strategic Investments Stocks To Watch Guide (go to:
http://www.iotogo.com/StocksToWatch) provides investors with essential information on stocks that may be poised for a significant move. By featuring... More...>> |
| 04/21/2008 | 8:00AM | PRNUS | 'Proud Hands' Book Released to Benefit the American Parkinson Disease Association
Teva Neuroscience Sponsors Book That Celebrates Daily Victories Over Parkinson's
NEW YORK, April 21 /PRNewswire/ -- Most people view an illness as a handicap. A number of people with Parkinson's disease (PD), an age-related degenerative disorder of the brain which normally affects people over the age of 60, have each... More...>> |
| 03/06/2008 | 12:56PM | PRNUS | Perrigo Company to Market Over-the-Counter Cetirizine Hydrochloride, Pseudoephedrine Hydrochloride Extended-Release Tablets
ALLEGAN, Mich., Mar. 6 /PRNewswire-FirstCall/ -- Perrigo Company (NASDAQ:PRGO)(TASE:PRGO) today announced that its partner, Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA), has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for over-the-counter... More...>> |
| 01/15/2008 | 9:31AM | PRNUS | Seven Summits Research Releases Alerts on C, EMC, GRMN, TEVA, and DF
CHICAGO, Jan. 15 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for key stocks.
Seven Summits Strategic Investments' PriceWatch Alerts are available at
http://www.iotogo.com/s/011508A (Note: You may have to copy this link into your browser then press the [ENTER] key.)
Today's PriceWatch Alerts cover... More...>> |
| 10/22/2007 | 7:30AM | PRNUS | Adenoscan(R) Patent Lawsuits Settled
Astellas, King and Item finalize settlement agreement with Teva
TOKYO, BRISTOL, Tenn., and JERUSALEM, Oct. 22 /PRNewswire/ -- Astellas Pharma Inc. ("Astellas"; headquarters: Tokyo; President and CEO: Masafumi Nogimori), King Pharmaceuticals, Inc. ("King"; NYSE: KG) and Teva Pharmaceutical Industries Ltd. ("Teva" Nasdaq:... More...>> |
| 06/08/2007 | 8:03AM | PRNUS | International Movement Disorder Specialists Receive New Information About the Use of Once-Daily AZILECT(R) in the Treatment of P
Results presented at the Movement Disorder Society's 11th International Congress in Istanbul, Turkey
KANSAS CITY, Mo., June 8 /PRNewswire-FirstCall/ -- New information on the use of AZILECT(R) (rasagiline tablets) for the treatment of Parkinson's disease (PD) was reported this week at The Movement Disorder Society's... More...>> |
| 05/02/2007 | 11:47AM | PRNUS | Seven Summits Research Releases Comments on VZ, GRMN, TEVA, GPS, and USG
CHICAGO, May 2 /PRNewswire/ -- Seven Summits Research releases NewsBites on key stocks.
Seven Summits Strategic Investments NewsBites are available to all investors at:
http://www.go7now.com/nb/0502Z (Note: You may have to copy this link into your browser then press the [ENTER] key.)
Today's Seven Summits Strategic... More...>> |
| 04/02/2007 | 1:09PM | PRNUS | Dawson James Securities Reiterates Strong Buy Recommendation on Antares Pharma (Amex: AIS) with $4.00 Price Target
BOCA RATON, Fla., April 2 /PRNewswire/ -- Dawson James Securities, a full- service investment firm serving the healthcare and biotechnology industry, reiterated their Strong Buy recommendation on Antares Pharma (AMEX:AIS) and a 12-18 month price target of $4.00. Stephen M. Dunn, Director of Research, issued the report.
The... More...>> |
| 02/27/2007 | 8:15AM | PRNUS | Vaccinex Announces Antibody Development and Commercialization Alliance in Multiple Sclerosis and Oncology
- Novel Antibody has Potential to Address Unmet Medical Need in Millions of Patients Worldwide -
ROCHESTER, N.Y., Feb. 27 /PRNewswire/ -- Vaccinex, Inc. announced today that it has entered into a collaboration with Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) to develop and commercialize VX15, a novel human antibody... More...>> |
| 01/18/2007 | 11:03AM | PRNUS | Seven Summits Research Releases Comments on EBAY, VZ, ERTS, NUE, and TEVA
CHICAGO, Jan. 18 /PRNewswire/ -- Seven Summits Research releases NewsBites on key stocks.
Seven Summits Strategic Investments NewsBites are available to all investors at http://www.go7now.com/nb.aspx?p=0118Z (Note: You may have to copy this link into your browser then press the [ENTER] key.)
Today's Seven Summits... More...>> |
| 12/22/2006 | 7:00AM | PRNUS | Largest Disease Modification Trial for Parkinson's Disease Completes Enrollment
Study to determine AZILECT(R) effect on slowing disease progression in approximately 1,200 recently diagnosed PD patients
KANSAS CITY, Mo., Dec. 22 /PRNewswire-FirstCall/ -- The largest clinical study to investigate disease modification in early Parkinson's disease (PD) has completed enrollment. The ADAGIO (Attenuation... More...>> |
| 11/06/2006 | 8:30AM | PRNUS | Elbit Medical Group Announces Receipt of a Special Protocol Assessment From the FDA to Gamida Cell's Stemex(R) Registration Stud
More...>> |
| 10/10/2006 | 8:30AM | PRNUS | New Analyses Further Support Benefits of Once-Daily AZILECT(R) in the Treatment of Both Early and More Advanced Parkinson's Dise
Results Presented at the 131st American Neurological Association Meeting
KANSAS CITY, Mo., Oct. 10 /PRNewswire-FirstCall/ -- New reports of AZILECT(R) (rasagiline tablets) as initial monotherapy, AZILECT(R) as first adjunctive therapy in moderate patients, and AZILECT(R) in combination with other adjunct agents in... More...>> |
| 09/25/2006 | 11:20AM | PRNUS | Seven Summits Research Releases Comments on QCOM, AMR, LRCX, TEVA, and EK
CHICAGO, Sept. 25 /PRNewswire/ -- Seven Summits Research releases NewsBites on key stocks.
Seven Summits Strategic Investments NewsBites are available to all investors at http://www.go7now.com/nb.aspx?p=0925Z (Note: You may have to copy this link into your browser then press the [ENTER] key.)
Today's Seven Summits... More...>> |
| 09/14/2006 | 11:13AM | PRNUS | Seven Summits Research releases comments on OXY, XMSR, XLNX, TEVA, and PIR
CHICAGO, Sept. 14 /PRNewswire/ -- Seven Summits Research releases NewsBites on key stocks.
Seven Summits Strategic Investments NewsBites are available to all investors at http://www.go7now.com/nb.aspx?p=0914Z (Note: You may have to copy this link into your browser then press the [ENTER] key.)
Today's Seven Summits... More...>> |
| 08/01/2006 | 11:46AM | PRNUS | Seven Summits Research releases comments on GM, TEVA, IACI, HLT, and IP
CHICAGO, Aug. 1 /PRNewswire/ -- Seven Summits Research releases NewsBites on key stocks.
Seven Summits Strategic Investments NewsBites are available to all investors at http://www.go7now.com/Newsbites (Note: You may have to copy this link into your browser then press the [ENTER] key.)
Today's Seven Summits Strategic... More...>> |
| 07/31/2006 | 6:45AM | PRNUS | Teva Neuroscience Announces AZILECT(R) Is Now Available in Pharmacies - the First, Once-Daily Treatment for Parkinson's Disease
New treatment option and its accompanying 'PD Exercise Kit' is a welcome addition to the PD community
KANSAS CITY, Mo., July 31 /PRNewswire-FirstCall/ -- Teva Neuroscience announced today the launch of AZILECT(R) (rasagiline tablets), the first, once-daily treatment for Parkinson's disease (PD) now available in pharmacies... More...>> |
|
|
|